Related by context. All words. (Click for frequent words.) 72 IMiDs ® 72 rxRNA 71 targeted radiotherapeutic 71 candidate deforolimus 71 Bayer HealthCare Onyx Pharmaceuticals 71 PDE4 inhibitor 71 2 methoxyestradiol 71 AKT inhibitor 71 oral ghrelin agonist 71 TELINTRA R 70 PI3K/Akt pathway inhibitor 70 Crofelemer budesonide foam 70 Personalized Immunotherapy 70 generation purine nucleoside 70 IMiDs R 70 MKC# MT 70 non nucleoside inhibitor 70 IMPDH inhibitor 70 humanized therapeutic 70 Panzem R 70 Myocet 70 pralatrexate injection folate analogue 70 Provectus Pharmaceuticals specializes 70 AFREZZA TM 70 MKC# MKC# PP 70 delivers fluocinolone acetonide FA 70 sapacitabine CYC# 69 THR beta agonist 69 hypoxia activated prodrug 69 AAG geldanamycin analog 69 SPL# Gel vaginal microbicide 69 delta opioid receptor 69 OvaRex R 69 delta gamma agonist 69 Inotek Pharmaceuticals Corporation 69 oncolytic virus therapies 69 kidney urologic 69 anticoagulant reversing agent 69 NB S# strontium malonate 69 Silodosin 69 metaglidasen 69 CYT# potent vascular disrupting 69 acyclovir Lauriad R 69 P#X# antagonist 69 LymphoStat B belimumab 68 DP VPA 68 molecular imaging radiopharmaceutical 68 including eniluracil ADH 68 tiapamil 68 Alfacell proprietary ribonuclease 68 GVAX ® 68 Syndax Pharmaceuticals Inc. 68 PF # [002] 68 platform HDL Mimetic 68 pharmacogenomic translational research 68 Initiates Enrollment 68 PTH analogue 68 oral proteasome inhibitor 68 t2cure GmbH 68 volociximab 68 Initiates Clinical Trial 68 non porcine pancreatic 68 toenail onychomycosis 68 Pruvel TM 68 Panzem R NCD 68 product platforms AZX# 68 ATRA IV 68 XL# anticancer compounds 68 PEGylated interferon 68 Gentamicin Surgical Implant 68 Pentad TM 68 TBC# 68 candidates Azedra TM 68 accumulate preferentially 68 novel therapeutic antibodies 68 MKC# 67 selective immunoproteasome inhibitor 67 acetonide FA 67 vapreotide acetate 67 dimebon latrepirdine 67 personalized cellular immunotherapy 67 ELND-#/AZD-# 67 Hsp# Inhibitor 67 ospemifene 67 Angiocept 67 therapeutic monoclonal antibody 67 delivery polymer matrix 67 Completes Patient Enrollment 67 SinuNase ™ 67 Arno Therapeutics 67 Empatic ™ 67 Files IND 67 Veronate R 67 cosmetic cosmeceutical products 67 PHX# 67 Liprotamase 67 PNP inhibitor 67 Ceflatonin R 67 SuperAntibody 67 oral anti arrhythmic 67 agonistic human 67 diabetes irritable bowel 67 albiglutide 67 Archexin 67 products Oncaspar ® 67 Initiates Phase II 67 investigational pharmacologically unique 67 Boniva ibandronate 67 liposomal formulation 67 Adnectin 67 cathepsin K inhibitor 67 IMiDs ® compound 67 Ridaforolimus 67 Warner Chilcott Actonel 67 fusion enhancers 67 ProLindac TM 67 nasal calcitonin product 67 Cloretazine VNP#M 67 Panzem ® 67 syndrome overactive bladder 67 oral prodrug 67 orally administered inhibitor 66 RhuDex TM 66 include VALSTAR TM 66 Bucindolol 66 coronary stent merged 66 hyaluronidase enzyme 66 romazarit 66 Elagolix 66 TRANSDUR ® 66 Qutenza TM 66 using VIAdel TM 66 selective estrogen receptor modulator 66 Oral NKTR 66 topically applied SEPA 66 hPTH #-# 66 neuronal nicotinic receptor NNR 66 treat secondary hyperparathyroidism 66 Selective Electrochemical Tumor Ablation 66 IAP inhibitor 66 vinorelbine tartrate 66 Locked Nucleic Acid LNA 66 DepoCyt ® Abelcet ® 66 Kahalalide F 66 Quinamed R 66 selective orally bioavailable 66 QNEXA ® 66 deCODE AF TM 66 receptor tyrosine kinase inhibitor 66 Prodarsan R 66 Trastuzumab DM1 66 Lixivaptan 66 Zolpimist ™ 66 product Fentanyl TAIFUN 66 orally inhaled 66 selective androgen receptor modulator 66 oral nucleoside analogue 66 overactive bladder AA# 66 pharmacologically active isomer 66 Peyronie disease Frozen Shoulder 66 novel oral anticoagulant 66 FOLFOX6 chemotherapy regimen 66 Syncria albiglutide 66 Empatic TM 66 proteasome inhibitor 66 triggers apoptosis programmed 66 Actonel risedronate 66 IAP inhibitors 66 vinca alkaloid 66 Albugon 66 novel immunotherapies 66 PORxin TM 66 EnteroMedics proprietary neuroblocking technology 66 PresbyLens ® 66 5 HT3 antagonist 66 label Lipofen R 66 OTCBB PYTO 66 oral immunomodulatory 66 Evoltra ® 66 Solazed TM 66 HepeX B TM 66 highly selective inhibitor 66 5 HT2A serotonin 66 Combivir Kivexa 66 progressive metastatic prostate 66 targeted antifolate 66 novel synthetic peptide 66 treat chronic sinusitis 66 TRIOLEX ™ 66 Intarcia 66 MTP inhibitor 66 candidate Zemiva 66 hormone LHRH antagonist 66 SIX RO ROG 66 XSSE OXGN 66 topical gel formulation 66 Initiates Clinical 66 Rigel R# 66 ARRY # 66 EVIZON TM squalamine lactate 66 Cardioxyl Pharmaceuticals 66 beta secretase inhibitors 66 Sphingomab TM 66 lipid nanoparticle 66 TOCOSOL Camptothecin 66 TRIOLEX HE# 66 Anticalins R 66 intranasal formulation 66 Xeloda ® 66 highly selective endothelin 65 TRACON Pharmaceuticals 65 Safinamide 65 docetaxel Taxotere R 65 Atripla combines 65 Tesetaxel 65 MAGE A3 ASCI 65 selective androgen receptor modulators 65 Locked Nucleic Acid 65 Transdermal Patch 65 novel immunomodulatory 65 HQK 65 reslizumab 65 oral PTH 65 Marqibo TM 65 KL4 Surfactant 65 ASONEP TM 65 PORxin TM platforms 65 neuropathic pain metabolic diseases 65 platinum chemotherapeutic 65 Pimavanserin 65 NuMimetic TM 65 DNA methyltransferase inhibitors 65 M# rationally 65 Squalamine 65 sorafenib tablets 65 Begins Dosing 65 small molecule thrombopoietin 65 hereditary emphysema 65 Epeius Biotechnologies Corporation 65 BHT DNA 65 About Positron Positron 65 Tramiprosate ALZHEMED TM 65 CDK cyclin dependent 65 Aganocide 65 Zelos Therapeutics 65 treat male hypogonadism 65 HEPLISAV TM hepatitis B 65 telomerase therapeutic 65 virus HCV protease inhibitor 65 Teikoku Pharma USA 65 EOquin TM phase 65 solid tumors ZYBRESTAT 65 Kosan dependence 65 Albuferon albinterferon alfa 2b 65 HCV RNA polymerase 65 Luramist TM 65 GEM OS2 65 allosteric modulator NAM 65 BENLYSTA TM 65 Budesonide foam crofelemer 65 Phase #b/#a clinical 65 promising anticancer 65 Mipomersen 65 Receptos 65 candidate Zemiva TM 65 FOLOTYN ® 65 leading oral taxane 65 Novosom 65 MP4 molecule 65 neovascular form 65 novel peptide 65 paclitaxel poliglumex 65 potent suppressor 65 oral dihydropyrimidine dehydrogenase DPD 65 R MSCRAMM 65 mGluR5 negative 65 orally inhaled migraine 65 muscarinic receptor agonist 65 recombinant PSMA vaccine 65 JAK2 Inhibitor 65 reformulates existing FDA 65 prokinetic agent 65 Hematide ™ 65 rusalatide acetate 65 oral salmon calcitonin 65 Phase III Pivotal 65 Thiarabine 65 sulfonylhydrazine class 65 Bazedoxifene 65 Anavex #-# 65 OvaRex ® MAb 65 hypoxia selective 65 initiate multicenter 65 ONCONASE R 65 tumor activated prodrug 65 Sapacitabine 65 Xcytrin R 65 novel VDA molecule 65 ALTROPANE R 65 oral Factor Xa 65 TRIOLEX HE# APOPTONE HE# 65 Wellstat 65 Unigene nasal calcitonin 65 peptidomimetic 65 methylnaltrexone bromide 65 LHRH antagonist 65 Juvaris BioTherapeutics 65 SAR# [002] 65 aldehyde dehydrogenase ALDH2 deficiency 65 inhaled formulation 65 Testosterone MDTS R 65 Voreloxin 65 apomorphine hydrochloride 65 PrevOnco ™ 65 Aeolus Pharmaceuticals Announces 65 Talabostat 65 ALN PCS 65 PDE4 modulators 65 oxazolidinone 65 Curaxin CBLC# 65 class mGluR5 inhibitor 65 GPR# agonist 65 bucindolol hydrochloride 65 RhuDex ® 65 Omacetaxine 65 dermatology therapies 65 use transdermal sumatriptan 65 GSK '# 65 PrevOnco 65 Nanobody R 65 anti CD3 monoclonal 65 RhuDex R 65 ART# 65 TNF Tumor Necrosis Factor 65 R sorafenib tablets 65 dasatinib Sprycel 65 Myolimus 65 lexidronam injection 65 Fc fusion protein 65 small molecule tyrosine 65 ENMD # 65 triciribine phosphate monohydrate 65 BiTE R 64 torsemide ER 64 sublingual formulation 64 epothilone 64 itraconazole Sporanox 64 Mg Usa 64 generation proteasome inhibitor 64 defensin mimetic antibiotic 64 TKB# 64 HepDirect R 64 investigational monoclonal antibody 64 GRNVAC1 64 candidate CRLX# 64 LEVADEX TM 64 Maribavir 64 doxepin HCl 64 overactive bladder VANTAS R 64 Presents Preclinical Data 64 RNA antagonists 64 Omnitarg 64 molecular imaging radiopharmaceuticals 64 Deforolimus 64 Cerimon Pharmaceuticals Inc. 64 TRANSDUR ™ 64 proprietary radiolabeled monoclonal 64 Investigational Oral 64 YONDELIS R 64 Temsirolimus 64 Phase IIb clinical trials 64 NS5B polymerase 64 small molecule Hedgehog 64 Celator 64 Successfully Completes Phase 64 tramiprosate Alzhemed TM 64 milnacipran HCl 64 mild vasodilator 64 bortezomib Velcade R 64 neuro inflammatory 64 HGS# 64 humanised monoclonal antibody 64 formerly LymphoStat B 64 evaluating satraplatin 64 candidates Azedra 64 products MKC# PP 64 Nitazoxanide 64 HCV polymerase inhibitors 64 IMiDs 64 serine protease inhibitor CU# 64 5 lipoxygenase activating 64 novel orally inhaled 64 neuropathic pain spasticity 64 orally disintegrating 64 gastrin analogue TT 64 modified glutathione analog 64 INS# [001] 64 confirmatory pivotal 64 anticancer compound 64 mertansine 64 VitiGam 64 recurrent metastatic ovarian cancer 64 VentiRx Pharmaceuticals 64 retinal vein occlusion induced 64 PSN# [001] 64 immunotherapeutic agent 64 AFREZZA ® 64 sarcoma melanoma 64 multitargeted 64 memantine HCl 64 candidate ATHX 64 Peginterferon alfa 2b 64 Zemiva TM 64 reversible inhibitor 64 midstage clinical 64 superparamagnetic iron oxide nanoparticles 64 mGluR2 positive 64 theranostic 64 Small Molecule 64 FoldRx Pharmaceuticals Inc. 64 5 HT2A inverse 64 ionotropic glutamate receptor antagonists 64 DUROS 64 Annamycin 64 candidate TNFerade biologic 64 PDE# inhibitors 64 melanocortin receptor agonists 64 Commences Phase 64 Cannabinor 64 Custirsen 64 immunotherapeutic vaccine 64 Intermezzo ® zolpidem tartrate 64 SinuNase TM 64 treat refractory angina 64 alvespimycin 64 systemic lupus erythematosus rheumatoid 64 class anticancer quinolone 64 IL# PE#QQR 64 INSPIRE Trial Phase III 64 oral Janus kinase 64 Mg Uk 64 expanded autologous cellular 64 Nipent R 64 2A receptor agonist 64 Alvine Pharmaceuticals 64 Nasdaq HALO biopharmaceutical 64 Sudhir Agrawal D.Phil 64 Receives Orphan Drug Designation 64 rhIGF-I/rhIGFBP-3 64 Prism Pharmaceuticals 64 Vitrasert R 64 Matrix Phase 2b 64 nilotinib Tasigna 64 targeted anticancer biopharmaceuticals 64 introduced NEUGENE 64 Vitamin D analogue 64 MVA HPV IL2 64 Chronogen 64 GLP1 INT TM 64 pan histone deacetylase 64 Hedgehog Pathway Inhibitor 64 taxane derivative 64 peripherally acting 64 Alexza Staccato 64 signal transduction inhibitor 64 somatostatin analog 64 use neuroblocking technology 64 using Innocoll proprietary 64 HYVISC ® treatment 64 Acetavance TM intravenous acetaminophen 64 prostone 64 albiglutide currently 64 Cardium Therapeutics TM 64 novel emulsion formulation 64 skeletal sarcomere activators 64 personalized dendritic 64 non thiazolidinedione TZD 64 Exelixis compounds 64 NPC 1C 64 Cerimon 64 Meets Primary Endpoint 64 Roche Boniva 64 KAI Pharmaceuticals 64 Guanilib 64 acadesine 64 CCR9 antagonist 64 ABL inhibitor 64 oral picoplatin 64 Exherin 64 refractory chronic lymphocytic 64 davalintide 64 Oral Suspension USP 64 selective antagonist 64 ALN HPN 64 CB2 selective receptor agonist 64 Combination REOLYSIN R 64 Pegloticase 64 development peramivir neuraminidase 64 reversible inhibitors 64 orally bioavailable 64 MacuSight 64 NASH Huntington 64 mesylate tablets approved 64 ocular formulation 64 antimitotic 64 BXT # 64 Currently RegeneRx 64 GW# [003] 64 POSIDUR TM ELADUR TM 64 adrenergic regulation 64 R DepoCyt 64 Eniluracil 64 dermatologic diseases 64 multicenter Phase III 64 MPH AMEX 64 LymphoStat B TM 64 NU# direct 64 calcitonin salmon nasal spray 64 compound INCB# 64 VEGFR2 inhibitor 64 Initiates Phase III 64 Delta opioid receptor 64 nilotinib Tasigna ® 64 TAFA# 64 cardio metabolic diseases 64 Imatinib mesylate 64 rALLy clinical trial 64 ATD TM gel 64 successfully commercialize Iluvien 64 Ceragenin ™ 64 HCV NS5B polymerase 64 RTP #i 64 Aganocide ® 64 Frozen Shoulder syndrome Adhesive 64 First Patient Dosed 63 DOS# 63 Adenoscan R 63 investigational HCV polymerase 63 Dementia Related Psychosis 63 nalbuphine ER 63 Iluvien ® 63 recombinant subunit vaccine 63 brivanib 63 Monoclonal antibody 63 erlotinib Tarceva ® 63 gastro intestinal inflammation 63 induced macular edema 63 pipeline ImmunoGen collaborators 63 essential thrombocythemia ET 63 Cara Therapeutics 63 Selzentry Celsentri 63 thetreatment 63 commercialize CorMedix drug 63 Gastrointestinal Liner 63 Auxilium transmucosal film 63 R olmesartan medoxomil 63 developing Bicifadine serotonin 63 ficlatuzumab 63 Cyclosert TM 63 Receives Approvable Letter 63 Milnacipran 63 Inhalation Powder 63 demonstrated antitumor activity 63 pan HDAC inhibitor 63 HDL Selective Delipidation 63 Æterna Zentaris Inc. 63 drug pipeline TAFA# 63 orally disintegrating formulation 63 SGLT Inhibitors 63 lucinactant 63 recombinant biopharmaceutical 63 beta 1a 63 HSP# inhibitor 63 Parathyroid hormone 63 please visit http:/www.vandapharma.com 63 LUCENTIS ® 63 HepDirect prodrug 63 Namenda Memantine HCl 63 peptibody 63 XL# XL# 63 Pertuzumab 63 Immunotherapeutic 63 XL# XL# XL# XL# 63 gets USFDA nod 63 MSCRAMM ® 63 cyclophilin inhibitors 63 nucleoside tide 63 Miraxion Amarin lead 63 Zorbtive TM 63 human IgG1 monoclonal 63 Chipscreen 63 ELADUR ™ 63 cisplatin gemcitabine 63 dasatinib Sprycel ® 63 transdermal gel 63 Enkephalin 63 enGene 63 diarrhea predominant irritable 63 staphylococcal vaccine 63 Dapagliflozin 63 nasally administered 63 R#/MEM # 63 clinical trials Archexin 63 Posiphen TM 63 R Saizen R 63 non nucleoside HCV 63 tubulin inhibitors 63 MDRNA proprietary 63 GEMS TM 63 octreotide implant 63 product platforms GVAX 63 IV Busulfex 63 investigational humanized monoclonal antibody 63 inhaled formulations 63 AcryMed Incorporated 63 MEK inhibitor 63 BUPHENYL R 63 Zenvia ™ 63 ATPace TM 63 Aciphex R 63 external counterpulsation systems 63 Angiotensin Converting Enzyme 63 novel orally administered 63 Phase Ib IIa 63 Elestrin ® 63 Duromist ™ 63 AzaSite ISV 63 investigational hepatitis C 63 KNS # 63 5 HT4 63 Phase 2b Trial 63 Craig Tooman 63 Onco TCS 63 Aflibercept 63 Aurora Kinase 63 4SC AG ISIN DE# 63 3 registrational trial 63 Oxytrex TM 63 BioFocus DPI Galapagos 63 Tumour Vascular Disrupting Agent 63 miconazole Lauriad ® 63 Pafuramidine 63 pentadentate logo R 63 Adenosine Therapeutics 63 utilizes InSite Vision 63 Kuvan sapropterin dihydrochloride 63 involuntary dyskinetic movements 63 oral beclomethasone dipropionate 63 Inc. AMEX YMI 63 Homspera TM 63 CINQUIL 63 Aplidin R 63 Pervasis Therapeutics Inc. 63 PEG SN# 63 AN# topical anti 63 Iloperidone 63 Nasdaq MNKD focused 63 SILENOR 63 EXPAREL TM 63 MCSP respectively 63 BRIM2 63 candidate AQ4N 63 Daclizumab 63 therapeutic monoclonal antibodies 63 PEGylated Fab fragment 63 Ophthotech 63 SILENOR TM doxepin HCl 63 Tesmilifene 63 proprietary PEGylation 63 NYSE Amex AEN 63 migraine headaches neuropathic pain 63 treats acute lymphoblastic 63 Elan NanoCrystal 63 anticancer therapeutics 63 BCR ABL inhibitors 63 Initiates Phase 2b 63 Novolimus 63 CRLX# 63 Anchor Therapeutics 63 DEB# 63 immunotherapeutic approaches 63 Tofacitinib 63 Calistoga Pharmaceuticals 63 BioNumerik 63 Meritage Pharma 63 CombinatoRx Incorporated 63 OncoVex 63 oxypurinol 63 HDL Mimetic Peptide 63 Zoraxel TM 63 Nexavar sorafenib tablets 63 Orally administered 63 Luteinizing Hormone Releasing Hormone 63 Sanofi Pasteur Fluzone 63 intravesical infusion therapy 63 AEG# 63 Proellex TM 63 either acutely decompensated 63 histone deacetylase inhibitor 63 Agios Pharmaceuticals 63 Technosphere ® 63 Tezampanel 63 RECOTHROM ® 63 DNAi 63 Georges Gemayel 63 TNFerade TM 63 sodium glucose transporter 63 candidate DB# 63 Etubics 63 HuMax TAC 63 Company Nasdaq RGDX 63 EHT AGN 63 erlotinib Tarceva R 63 CORTOSS R 63 sulfonylurea glimepiride 63 constipation OIC 63 intranasal insulin product 63 ® bortezomib 63 sorafenib tablets small 63 HIV maturation inhibition 63 Presents Preclinical 63 systemic juvenile idiopathic 63 Tyrima 63 Therapeutic Competitors Companies 63 rivastigmine Exelon 63 anionic backbone 63 enhance ApoA 63 Catalyst Biosciences 63 Eraxis 63 Nasdaq VNDA 63 infectious diseases autoimmune diseases 63 trastuzumab Herceptin R 63 commercializing oxidized glutathione 63 selective kinase inhibitor 63 Zeldox 63 Opterone R 63 Nektar proprietary 63 sirtuin inhibitor program 63 diagnostic molecular imaging 63 CTAP# Capsules 63 rxRNA TM compounds 63 Nereus Pharmaceuticals 63 OTCBB URGP specialty 63 Syncria 63 ADP receptor antagonist 63 Agile Therapeutics 63 commercialize deforolimus 63 optical biosensors 63 selective A2A adenosine receptor 63 Solazed 63 Spiegelmer ® 63 REGiMMUNE 63 Phase 1b clinical trials 63 NASDAQ INFI 63 Nanobody 63 epigenetic therapies 63 long acting muscarinic 63 APR Labtec 63 specific CCR9 antagonist 63 Captisol ® 63 nasally delivered 63 isoform selective 63 renin inhibitors 63 RenaZorb TM 63 PGL# 63 Levoleucovorin 63 Lodotra TM 63 sitaxsentan 63 candidate Hematide TM 63 cromolyn sodium 63 motexafin gadolinium Injection 63 Fosphenytoin 63 NexGenix 63 ASG 5ME 63 Intravitreal 63 brand ciclesonide HFA 63 Genasense oblimersen sodium Injection 63 HuCAL antibodies 63 ORTHOCON 63 small molecule glucokinase 63 topically delivered 63 chimeric monoclonal antibody 63 oral dual endothelin 63 PDX pralatrexate 63 oral calcitonin licensed 63 Factor VIIa 63 neuroblocking technology 63 Cathepsin S 63 multi kinase inhibitor 63 vaginally administered lidocaine 63 DG# compounds targeting 63 nucleoside analog 63 proprietary intravenous formulation 63 MyoCell TM 63 includes AstraZeneca Accolate 63 Xanthus Pharmaceuticals Inc. 63 Mark A. Sirgo 63 SansRosa 63 trastuzumab DM1 T DM1 63 SYN# 63 Anidulafungin 63 Solzira ™ 63 OMP #R# 63 candidate REP# 63 MOVIPREP R 63 adenosine A2A 63 Virdante 63 Anticalin R 63 Ecallantide 62 seliciclib CYC# 62 Nutra Pharma wholly owned 62 myelofibrosis polycythemia vera 62 initiated Phase 1b 62 Qnexa TM 62 HGS ETR1 mapatumumab 62 InfaCare Pharmaceutical Corporation 62 norepinephrine reuptake inhibitor 62 protein tyrosine phosphatase 1B 62 PREOS R 62 http:/www.unigene.com 62 Vidaza R 62 PLX STROKE targeting 62 investigational compounds 62 ATL# [002] 62 Pruvel ™ 62 Afferent Pharmaceuticals 62 MEDAREX 62 Curaxin 62 ELADUR TM 62 Letairis ambrisentan 62 6 sulfatase 62 candidate ridaforolimus 62 OMNARIS HFA 62 activate SIRT1 62 platforms GVAX 62 receptor inhibiting monoclonal 62 Phase III multicenter 62 Simulect 62 Genasense ® oblimersen 62 Onalta TM 62 GERD migraine headaches 62 constipation predominant irritable bowel 62 Zosano 62 Diabetic Macular Edema DME 62 ALN VSP Phase 62 Curis collaborator Genentech 62 Pitavastatin 62 EOS NASDAQ MELA 62 drugs FUSILEV 62 oral antiplatelet agent 62 vidofludimus 62 novel histone deacetylase 62 Protalex Inc. 62 nanopharmaceutical 62 YONDELIS 62 Diasome 62 Plavix clopidogrel bisulfate 62 Quinamed 62 Oral Calcitonin 62 non resectable metastatic 62 dextromethorphan quinidine 62 Cleviprex TM clevidipine 62 blinded randomized placebo controlled 62 DU #b 62 AdhTAP 62 ProEthic Pharmaceuticals 62 DCVax R 62 thiazolides 62 Teriflunomide 62 CYP#A# CYP#D# 62 CTA# Injection 62 treat lupus renal 62 Brussels THR 62 RAF kinase 62 product candidate Lpathomab 62 drug GAP #B# 62 cetuximab Erbitux R 62 Onconase 62 PRT# 62 therapeutic mAbs 62 nitric oxide donating prostaglandin 62 Oxytrol R 62 Civacir 62 selective inverse agonist 62 Shows Promise Against 62 Ovitrelle R Serostim 62 Ixabepilone 62 Romidepsin 62 RNAi Therapeutic 62 orally ingestible insulin 62 sodium glucose cotransporter 62 delivered RNAi therapeutic 62 Anti VEGF 62 Elotuzumab 62 JVRS 62 Vytorin combines 62 sublingual tablet formulation 62 AERx R 62 registrational Phase 62 multicenter Phase II 62 RAS MAPK pathway 62 protein kinase inhibitors 62 By JAMAAL ABDUL 62 RONDEL ™ 62 transmucosal delivery 62 PhaseBio 62 Cetrorelix 62 Launches Generic Version 62 hypertension osteoarthritis 62 Oral Insulin 62 Oracea TM 62 Belimumab 62 CTAP# 62 FivePrime Therapeutics 62 RANK Ligand inhibitor 62 MicuRx 62 Investigational Treatment 62 DURIN TM 62 dopamine D2 62 faropenem medoxomil 62 cisplatin carboplatin 62 NovaBay Aganocide 62 HCV protease inhibitors 62 negative allosteric modulator 62 Wadih Arap 62 purified inactivated vaccine 62 Aegis Therapeutics 62 JZP 62 investigational pan BCR 62 octreotide acetate 62 obesity dyslipidemia 62 lintuzumab SGN 62 EVIZON ™ 62 Augment TM 62 Addrenex Pharmaceuticals 62 PRLX # 62 Phase 2b Clinical Trial 62 paclitaxel Taxol ® 62 proven DuraSite ® 62 approved incretin mimetic 62 ® lenalidomide 62 Initiate Phase 62 immunologic diseases 62 Vidaza ® 62 mda 7 62 Robert L. Bratzler 62 Systemic Sclerosis 62 TARIS Biomedical 62 biased ligand 62 receptor modulators 62 gastrointestinal stromal 62 Announces Tentative Approval 62 Darinaparsin 62 visilizumab 62 Cerashield ™ 62 iSONEP ™ 62 Conatus Pharmaceuticals 62 orally bioavailable mimics 62 Micromet proprietary BiTE 62 Initiates Clinical Trials 62 NEBIDO VANTAS SUPPRELIN LA 62 Technology LVT 62 Atrigel 62 Horizant ™ 62 oxybutynin ATD TM 62 sodium Injection 62 Decision Biomarkers 62 Inc. Nasdaq VIAP 62 REG2 62 Ception Therapeutics 62 Namenda ® 62 R Abelcet 62 Epothilones 62 Cobalamin TM mediated 62 NYSE Amex PBTH 62 EVIZON TM 62 LUNESTA TM 62 Panzem NCD 62 Bremelanotide 62 HCV protease inhibitor 62 Naglazyme R 62 IMPACS R 62 Nexavar ® 62 CD# CEA 62 HuCAL GOLD R 62 sodium thiosulfate STS 62 NeutroSpec TM 62 ThermoDox ® clinical 62 Valtropin 62 arsenic trioxide injection 62 evaluating tivozanib 62 ALS #-# 62 apoptosis inducers 62 TELINTRA 62 apricitabine ATC 62 Affimed Therapeutics AG 62 DDP# 62 Tykerb lapatinib 62 mitogen activated ERK kinase